SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Kremer Leontien C.)
 

Sökning: WFRF:(Kremer Leontien C.) > Risk of subsequent ...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00007099naa a2200793 4500
001oai:lup.lub.lu.se:87322128-6969-4e7b-8cb5-7e49bf0c6b92
003SwePub
008240216s2024 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:154785539
0247 a https://lup.lub.lu.se/record/87322128-6969-4e7b-8cb5-7e49bf0c6b922 URI
0247 a https://doi.org/10.1038/s41416-024-02577-y2 DOI
0247 a http://kipublications.ki.se/Default.aspx?queryparsed=id:1547855392 URI
040 a (SwePub)lud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
1001 a Heymer, Emma J.u University of Birmingham4 aut
2451 0a Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe : the PanCareSurFup study
264 1c 2024
520 a Background: Childhood cancer survivors are at risk of subsequent gliomas and meningiomas, but the risks beyond age 40 years are uncertain. We quantified these risks in the largest ever cohort. Methods: Using data from 69,460 5-year childhood cancer survivors (diagnosed 1940–2008), across Europe, standardized incidence ratios (SIRs) and cumulative incidence were calculated. Results: In total, 279 glioma and 761 meningioma were identified. CNS tumour (SIR: 16.2, 95% CI: 13.7, 19.2) and leukaemia (SIR: 11.2, 95% CI: 8.8, 14.2) survivors were at greatest risk of glioma. The SIR for CNS tumour survivors was still 4.3-fold after age 50 (95% CI: 1.9, 9.6), and for leukaemia survivors still 10.2-fold after age 40 (95% CI: 4.9, 21.4). Following cranial radiotherapy (CRT), the cumulative incidence of a glioma in CNS tumour survivors was 2.7%, 3.7% and 5.0% by ages 40, 50 and 60, respectively, whilst for leukaemia this was 1.2% and 1.7% by ages 40 and 50. The cumulative incidence of a meningioma after CRT in CNS tumour survivors doubled from 5.9% to 12.5% between ages 40 and 60, and in leukaemia survivors increased from 5.8% to 10.2% between ages 40 and 50. Discussion: Clinicians following up survivors should be aware that the substantial risks of meningioma and glioma following CRT are sustained beyond age 40 and be vigilant for symptoms.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
7001 a Hawkins, Michael M.u University of Birmingham4 aut
7001 a Winter, David L.u University of Birmingham4 aut
7001 a Teepen, Jop C.u Princess Maxima Center for Pediatric Oncology/Hematology4 aut
7001 a Sunguc, Cerenu University of Birmingham4 aut
7001 a Ronckers, Cécile M.u Princess Maxima Center for Pediatric Oncology/Hematology,Johannes-Gutenberg University Mainz4 aut
7001 a Allodji, Rodrigue S.u Centre for Research in Epidemiology and Population Health (CESP)4 aut
7001 a Alessi, Danielau University of Turin4 aut
7001 a Sugden, Elaineu University of Birmingham4 aut
7001 a Belle, Fabiën N.u University of Bern,University of Lausanne4 aut
7001 a Bagnasco, Francescau Gaslini Children's Hospital4 aut
7001 a Byrne, Julianneu Boyne Research Institute4 aut
7001 a Bárdi, Editu Kepler University Hospital Linz,St. Anna Children's Hospital4 aut
7001 a Garwicz, Stanislawu Lund University,Lunds universitet,Sena effekter efter barncancerbehandling,Forskargrupper vid Lunds universitet,Late effects after childhood cancer treatment,Lund University Research Groups4 aut0 (Swepub:lu)st6750ga
7001 a Grabow, Desireeu Johannes-Gutenberg University Mainz4 aut
7001 a Jankovic, Momcilou University of Milano-Bicocca4 aut
7001 a Kaatsch, Peteru Johannes-Gutenberg University Mainz4 aut
7001 a Kaiser, Melanieu Johannes-Gutenberg University Mainz4 aut
7001 a Michel, Giselau University of Lucerne4 aut
7001 a Schindera, Christinau University Children's Hospital, Basel,University of Bern4 aut
7001 a Haddy, Nadiau Centre for Research in Epidemiology and Population Health (CESP)4 aut
7001 a Journy, Neigeu Centre for Research in Epidemiology and Population Health (CESP)4 aut
7001 a Česen Mazić, Majau University Children's Hospital, Ljubljana4 aut
7001 a Skinner, Rodericku University of Newcastle upon Tyne4 aut
7001 a Kok, Judith L.u Princess Maxima Center for Pediatric Oncology/Hematology4 aut
7001 a Gunnes, Maria W.u Norwegian Radium Hospital,Cancer Registry of Norway, Institute of Population-Based Cancer Research4 aut
7001 a Wiebe, Thomasu Lund University,Lunds universitet,Sena effekter efter barncancerbehandling,Forskargrupper vid Lunds universitet,Late effects after childhood cancer treatment,Lund University Research Groups4 aut0 (Swepub:lu)pedi-twi
7001 a Sacerdote, Carlottau University of Turin4 aut
7001 a Maule, Milena M.u University of Turin4 aut
7001 a Terenziani, Monicau Istituto Nazionale dei Tumori4 aut
7001 a Jakab, Zsuzsannau Semmelweis University4 aut
7001 a Winther, Jeanette F.u Danish Cancer Society,Aarhus University Hospital4 aut
7001 a Lähteenmäki, Päivi M.u Turku University Hospital4 aut
7001 a Zadravec Zaletel, Lornau Institute of Oncology, Ljubljana4 aut
7001 a Haupt, Riccardou Gaslini Children's Hospital4 aut
7001 a Kuehni, Claudia E.u University of Bern,University Children's Hospital Bern4 aut
7001 a Kremer, Leontien C.u Princess Maxima Center for Pediatric Oncology/Hematology,Academic Medical Center of University of Amsterdam (AMC)4 aut
7001 a de Vathaire, Florentu Centre for Research in Epidemiology and Population Health (CESP)4 aut
7001 a Hjorth, Larsu Lund University,Lunds universitet,Pediatrik, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Sena effekter efter barncancerbehandling,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Paediatrics (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,Late effects after childhood cancer treatment,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Skåne University Hospital4 aut0 (Swepub:lu)pedi-lhj
7001 a Reulen, Raoul C.u University of Birmingham4 aut
7102 a University of Birminghamb Princess Maxima Center for Pediatric Oncology/Hematology4 org
7730 t British Journal of Cancerg 130:6, s. 976-986x 0007-0920
7730 t British journal of cancerg 130:6, s. 976-986q 130:6<976-986x 1532-1827
8564 u http://dx.doi.org/10.1038/s41416-024-02577-yx freey FULLTEXT
8564 8u https://lup.lub.lu.se/record/87322128-6969-4e7b-8cb5-7e49bf0c6b92
8564 8u https://doi.org/10.1038/s41416-024-02577-y
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:154785539

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy